comparemela.com

Latest Breaking News On - சீர்குலைக்கும் தொழில்நுட்பங்கள் கண்டுபிடிப்பு நிதி - Page 2 : comparemela.com

Lárionad Acmhainní Nádúrtha CTR to take part in new research project - Highland Radio

Lárionad Acmhainní Nádúrtha CTR, an Údarás na Gaeltachta client based in An Fál Carrach is to participate in cutting edge research based on new farming methods. The E-Crop project will work towards developing innovative farming technologies and tools for farmers and the agriculture sector to improve and monitor crop health. Using cutting edge genomic and biological research and appropriate testing in An Fál Carrach it is hoped to develop innovative methods and tools that will provide further protections to seeds from various diseases hence promoting crop health. The project is being run in partnership with University College, Dublin, e-Seed Crop Technology Solutions Ltd, SeqBiome Ltd; and Origin Enterprises Public Ltd Company.

Trinity researchers secure government funding for next generation therapies for incurable cancers

These updates are republished press releases and communications from members of the Science|Business Network Trinity researchers secure government funding for next generation therapies for incurable cancers Researchers at the Trinity Translational Medicine Institute (TTMI) are part of a successful consortium to secure €6.8M government funding as part of a 3-year, €10.5M programme to develop next generation cell therapies for cancer. The HEALED consortium is one of 29 projects that the government has funded under the Disruptive Technologies Innovation Fund (DTIF) which is managed and funded through the Department of Enterprise and Innovation (DBEI) in Ireland. The research team at TTMI at St James’s Hospital have partnered with RemedyBio, aCGT Vector DAC and the SFI Centre for Research Training (CRT) in Genomics Data Science at NUIG to create the HEALED Consortium

AVECTAS Leads €7 23 million Consortium Awarded Part Funding From Ireland s Disruptive Technologies Innovation Fund

AVECTAS Leads €7.23 million Consortium Awarded Part Funding From Ireland’s Disruptive Technologies Innovation Fund Funding to develop high throughput cell engineering technology to manufacture off the shelf cell therapies Project, led by Avectas in partnership with Bluebridge Technologies and National Institute for Bioprocessing Research and Training (NIBRT), would support Ireland s goal of being at the forefront of cell therapy manufacturing Kildare, Ireland and Cambridge, MA, USA … Friday 23 April 2021.  Irish cell engineering company, Avectas, is leading a consortium which will invest €7.23 million, including €4.4 million awarded under the Irish Government’s Disruptive Technology Innovation Fund (DTIF), to develop a high-throughput scale of its proprietary cell engineering platform Solupore®. With consortium partners Bluebridge Technologies and NIBRT, the project expands Avectas development towards commercialising an advanced large-scale, digitalised cell engin

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.